Sadhana Nitro Chem: Funds Used as Planned
Reader Takeaway: Funds used as planned for new facility; ₹11.58 Cr balance for ongoing working capital needs.
Filing Details
Sadhana Nitro Chem Limited has filed its first Monitoring Agency Report for the quarter ending March 31, 2026. Acuite Ratings and Research Limited prepared the report, confirming that the funds raised through its Rights Issue have been used in line with the company's stated objectives. A total of ₹251.95 crore has been deployed, with ₹11.58 crore remaining unutilized.
Why This Matters to Investors
This filing provides important financial assurance to investors. It shows that the company's capital expenditure plans and operational expansion are progressing as communicated when the Rights Issue was launched. Following fund utilization commitments demonstrates financial discipline.
Rights Issue Background
Sadhana Nitro Chem launched a Rights Issue totaling ₹263.53 crore. The main goal of this fundraising was to build a new greenfield manufacturing facility for Nitrocellulose and related ancillaries. Part of the funds was also set aside to strengthen the company's working capital.
Key Takeaways
- Investors have confirmation that their capital is being deployed according to the company's strategic plans.
- The company shows financial discipline and commitment to executing its projects.
- The path for using the remaining funds for working capital is clear.
Potential Risks
- While fund utilization is confirmed, timely and efficient deployment of the remaining ₹11.58 crore for working capital remains important.
- Any delays in bringing the new manufacturing facility online could pose a risk.
Industry Landscape
Sadhana Nitro Chem operates within the specialty chemicals sector. Key players such as Navin Fluorine International Ltd and Clean Science and Technology Ltd are active in this area, though with different product focuses. These competitors highlight the competitive and dynamic nature of India's specialty chemicals market.
Key Figures
- Rights Issue Size: ₹263.53 Cr
- Funds Utilized: ₹251.95 Cr as of March 31, 2026 (Q4 FY26)
- Unutilized Funds: ₹11.58 Cr as of March 31, 2026 (Q4 FY26)
What to Watch Next
- The company's progress in utilizing the remaining ₹11.58 crore within the next 30-45 days.
- Updates on the new Nitrocellulose manufacturing facility's commissioning and production ramp-up.
- The company's ongoing financial performance and operational efficiency following the facility expansion.
